Central retinal vein occlusion is usually a disease of the elderly and is often associated with systemic vascular disease, e.g., hypertension, diabetes mellitus, arteriosclerotic vascular disease. Younger patients, especially those less than 45 years of age, with retinal vein occlusion should be evaluated carefully for the possibility of an underlying thrombotic tendency. The authors describe the ocular manifestations, pathogenesis, associated conditions, patient evaluation, and treatment of patients with central retinal vein occlusion.
GreenW.R., ChanC.C., HutchinsG.M., TerryJ.M.. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases.Trans Am Ophthalmol Soc1981; 79: 371–422.
2.
KleinB.A., OlwinJ.H.. A survey of the pathogenesis of retinal venous occlusion.Arch Ophthalmol1956; 56: 207–47.
3.
HayrehS.S.. Pathogenesis of occlusion of the central retinal vein.Am J Ophthalmol1971; 72: 998–1011.
4.
DodsonP.M., KubickiA.J., TaylorK.G., KritzingerE.E.. Medical conditions underlying recurrence of retinal vein occlusion.Br J Ophthalmol1985; 69: 493–6.
5.
McGrathM.A., WechslerF., HunyorA.B.L., PennyR.. Systemic factors contributory to retinal vein occlusion.Arch Int Med1978; 138: 216–20.
6.
GutmanF.A.. Evaluation of a patient with central retinal vein occlusion.Ophthalmology1983; 90: 481–3.
7.
DodsonP.M., GaltonD.J., WinderA.F.. Retinal vascular abnormalities in the hyperlipidemias.Trans Ophthalmol Soc UK1981; 101: 17–21.
8.
DodsonP.M., GaltonD.J., HamiltonA.M., BlachR.K.. Retinal vein occlusion and the prevalence of lipoprotein abnormalities.Br J Ophthalmol1982; 66: 161–4.
9.
DodsonP.M., WestwickJ., MarksG., KakkarV.V., GaltonD.J.. Beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion.Br J Ophthalmol1983; 67: 143–6.
10.
PriluckI.A.. Impending central retinal vein occlusion associated with increased platelet aggregability.Ann Ophthalmol1979; 11: 79–84.
11.
HeckerlingP.S., FroelichC.J., SchadeS.G.. Retinal vein thrombosis in a patient with pernicious anemia and anticardiolipin antibodies.J Rheum1989; 16: 1144–6.
SynersB., LambertM., HardyJ.. Retinal and choroidal vaso-occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies.Retina1990; 10: 255–60.
14.
AppiahA.P., TrempeC.L.. Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions.Ophthalmology1989; 96: 364–6.
15.
LarocheL., SarauxH.. Unilateral central retinal vein occlusion in systemic lupus erythematosus.Ophthalmologica1984; 189: 128–9.
16.
AvashiaJ.H., FathD.F.. Bilateral central retinal vein occlusion in Waldenstrom's macroglobulinemia.J Am Optomet Assoc1989; 60: 657–8.
17.
OrellanaJ., FreidmanA.H.. Ocular manifestations of multiple myeloma, Waldenstrom's macroglobulinemia and benign monoclonal gammopathy.Surv Ophthalmol1981; 26: 157–69.
18.
HayasakaS., UgomoriS., KodamaT., NodaS., SetogawaT.. Central retinal vein occlusion in two patients with immunoglobulin G multiple myeloma associated with blood hyperviscosity.Ann Ophthalmol1993; 25: 191–4.
ChernS., MagargalL.E., BravS.S.. Bilateral central retinal vein occlusion as an initial manifestation of pseudotumor cerebri.Ann Ophthalmol1991; 23: 54–7.
25.
ChernS., MagargalL.E., AnnesleyW.H.. Central retinal vein occlusion associated with drusen of the optic disc.Ann Ophthalmol1991; 23: 66–9.
26.
MagargalL.E., GonderJ.R., MaherV.. CRVO in the young adult.Trans PA Acad Ophthalmol and Otolaryngol1985; 37: 148–53.
27.
GiuffréG.. Tilted discs and central retinal vein occlusion.Graefe's Arch Clin & Exp Ophthalmol1993; 231: 41–2.
28.
LureauM.A., Glacet-BernardA., CoscasG.. Bilateral central retinal vein occlusion and lupus anticoagulant antibody.J Francais d'Ophtalmologie1995; 18468–72.
29.
CowleyM., CampochiaroP.A., NewmanS.A., FogleJ.A.. Retinal vascular occlusion without retrobulbar or optic nerve sheath hematoma after retrobulbar injection of lidocaine.Ophthalmic Surg1988; 19: 859–61.
30.
MorganC.M., SchatzH., VineA.K.Ocular complications associated with retrobulbar injections.Ophthalmology1988; 95: 660–5.
31.
GiuffréG., VadaláM., ManfréL.. Retrobulbar anesthesia complicated by combined central retinal vein and artery occlusion and massive vitreoretinal fibrosis.Retina1995; 15: 439–41.
32.
FongA.C., SchatzH., McDonaldH.R.Central retinal vein occlusion in young adults (papillophlebitis).Retina1992; 12: 3–11.
33.
PriluckI.A., RobertsonD.M., HollenhorstR.W.. Long term follow-up of occlusion of the central vein in young adults.Am J Ophthalmol1980; 90: 190–202.
34.
BernardA.G., CoscasG., ChabanelA., ZourdaniA., LelongF., SamamaM.. Prognostic factors for retinal vein occlusion. A prospective study of 175 cases.Ophthalmology1996; 103: 551–60.
35.
YoshizumiM.O., Townsend-PicoW.. Essential thrombocythemia and central retinal vein occlusion with neovascular glaucoma.Am J Ophthalmol1996; 121: 728–30.
36.
FongA.C.O., SchatzH.. Central retinal vein occlusion in young adults.Surv Ophthalmol1993; 37: 393–18.
37.
QuinlanP.M., ElmanM.J., BhattA.K., MardesichP., EngerC.. The natural course of central retinal vein occlusion.Am J Ophthalmol1990; 110: 118–23.
38.
BernardA.G., ChanabelA., LelongF., SamamaM.M., CoscasG.. Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors.Ophthalmology1994; 101: 1483–7.
39.
LuckieA.P., WroblewskiJ.J., BirdA.C., HamiltonA.M., SandersM.D., GreenW., SlaterN.G.. The venous closing pressure in central retinal vein obstruction.Aust N Z J Ophthalmol1996; 24: 233–8.
40.
SchatzH., FongA.C., McDonaldH.R.Ciliary retinal artery occlusion in young adults with central retinal vein occlusion.Ophthalmology1991; 98: 594–601.
41.
The Central Vein Occlusion Study Group.Natural history and clinical management of central retinal vein occlusion.Arch Ophthalmol1997; 115: 486–91.
42.
Glacet-BernardA., CoscasG., ChabanelA., ZourdaniA., LelongF., SamamaM.M.. Prognostic factors for retinal vein occlusion: prospective study of 175 cases.Ophthalmology1996; 103: 551–60.
43.
KohnerE.M., CappinJ.M.. Do medical conditions have an influence on central retinal vein occlusions?Proc R Soc Med1974; 67: 1052–4.
ChenV., MoisseievJ., TreisterG.. Severe ischemic process in a young man with central retinal vein occlusion.Metabolic, Ped Sys Ophthalmol1988; 11: 67–9.
53.
HayrehS.S., RojasP., PodhajskyP., MontagueP., WoolsonR.F.. Ocular neovascularization and retinal vascular occlusion - III. Incidence of ocular neovascularization with retinal vein occlusion.Ophthalmology1983; 90: 488–506.
54.
GreenW.R., ChanC.C., HutchinsG.M., TerryJ.M.. Central retinal vein occlusion: A prospective histopathological study of 29 eyes in 28 cases.Trans Am Ophthalmol Soc1981; 79: 371–422.
55.
VineA.K., SamamaM.M.. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions.Surv Ophthalmol1993; 37: 283–92.
56.
GlueckC.J., BellH., VadlamaniL.Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion.Arch Ophthalmol1999; 117: 43–9.
57.
IijimaH., GohdoT., ImaiM., TsukaharaS.. Thrombin-antithrombin III complex in acute retinal vein occlusion.Am J Ophthalmol1998; 126: 677–82.
58.
IannacconeA., LetiziaC., PazzagliaS., VingoloE.M., ClementeG., PannaraleM.R.. Plasma endothelin-1 concentrations in patients with retinal vein occlusions.Br J Ophthalmol1998; 82: 498–503.
59.
AppenR.E., DeVeneciaG., FerwerdeJ.. Optic disk vasculitis.Am J Ophthalmol1980; 90: 352–9.
60.
ChenH.C., GuptaA., WiekJ., KohnerE.M.. Retinal blood flow in nonischemic central retinal vein occlusion.Ophthalmology1998; 105: 772–5.
61.
Pe'erJ., FolbergR., ItinA., GnessinH., HemoI., KeshetE.. Vascular endothelial growth factor upregulation in human central retinal vein occlusion.Ophthalmology1998; 105: 412–6.
62.
The Eye Disease Case-Control Study Group.Risk factors for central retinal vein occlusion.Arch Ophthalmol1996; 114: 545–54.
63.
MitchellP., SmithW., ChangA.. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study.Arch Ophthalmol1996; 114: 1243–7.
64.
DodsonP.M., KritzingerE.E.. Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion.Trans Ophthalmol Soc UK1985; 104: 114–9.
65.
MurataM., NakagawaM., TakahashiS.. Molecular variant of the human paraoxonase/arylesterase gene is associated with central retinal vein occlusion in the Japanese population.Ophthalmologica1998; 212: 257–9.
66.
YoshizumiM.O., Townsend-PicoW.. Essential thrombocythemia and central retinal vein occlusion with neovascular glaucoma.Am J Ophthalmol1996; 121: 728–30.
67.
Basic and Clinical Science Course.American Academy of Ophthalmology. Section 10: 1995–6.
68.
DobreeJ.H.. Venous obstruction and neovascularization at the disc in chronic glaucoma.Trans Ophthalmol Soc UK1957; 77: 229–38.
DevS., HerndonL., ShieldsM.B.. Retinal vein occlusion after trabeculectomy with mitomycin C.Am J Ophthalmol1996; 122: 574–5.
71.
PrinceH.M., ThurlowP.J., BuchananR.C., IbrahimK.M.A., NeesonP.J.. Acquired protein S deficiency in a patient with systemic lupus erythematous causing central retinal vein thrombosis.J Clin Pathol1995; 48: 387–9.
72.
RirieD.G., CosgriffT.M., MartinB.. Central retinal vein occlusion in a patient with familial antithrombin III deficiency: Case report.Ann Ophthalmol1979; 11: 1841–5.
GladsonC.L., ScharrerI., HachV., BeckK.H., GriffinJ.H.. The frequency of type I heterogeneous protein S and protein C deficiency in 141 unrelated patients with venous thrombosis.Throm & Haemost1988; 59: 18–22.
75.
PetersonR.A., KrullP.E., FinleyP.. Changes in antithrombin III and plasminogen induced by oral contraceptives.J Clin Pathol1970; 53: 468–73.
76.
DhoteR., BachmeyerC., HorrellouM.M., ToulonP., ChristoforovB.. Central retinal vein thrombosis associated with resistance to activated protein C.Am J Ophthalmol1995; 120: 388–9.
77.
GrevenC.M., WeaverR.G., OwenJ., SlusherM.M.. Protein S deficiency and bilateral branch retinal artery occlusion.Ophthalmology1991; 98: 33–4.
78.
GolubB.M., SibonyP.A., CollerB.S.. Protein S deficiency associated with central retinal artery occlusion.Arch Ophthalmol1990; 108: 918.
79.
SpagnoloB.V., NasrallahF.P.. Bilateral retinal vein occlusion associated with factor V Leiden mutation.Retina1998; 18: 377–8.
80.
NybergP., DahlbackB., Garcia de FrutosP.. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function.FEBS Letters1998; 433: 28–32.
81.
KrugerK., AngerV.. Ischemic occlusion of the central retinal vein and protein C deficiency.J Francais d'Ophtalmologie1990; 13: 369–71.
82.
SvenssonP.J., DahlbackB.. Resistance to activated protein C as a basis for venous thrombosis.N Engl J Med1994; 330: 517–22.
83.
KosterT., RosendaalF.R., de RondeH., BrietE., VandenbrouckeJ.P., BertinaR.M.. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study.Lancet1993; 342: 1503–6.
84.
GreengardJ.S., SunX., XuX., FernandezJ.A., GriffinJ.H., EvattB.. Activated protein C resistance caused by Arg 506 Gln mutation in factor Va.Lancet1994; 343: 1361–2.
85.
KohnerE.M., PettitJ.E., HamiltonA.M., BulpittC.J., DolleryC.T.. Streptokinase in central retinal vein occlusion: a controlled clinical trial.Br Med J1976; 1: 550–3.
86.
GottliebJ.L., BliceJ.P., MestichelliB., KonkleB.A., BensonW.E.. Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults.Arch Ophthalmol1998; 116: 577–9.
87.
WilliamsonT.H., RumleyA., LoweG.D.O.. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.Br J Ophthalmol1996; 80: 203–8.
88.
LarssonJ., OlafsdottirE., BauerB.. Activated protein C resistance in young adults with central retinal vein occlusion.Br J Ophthalmol1996; 80: 200–2.
89.
GrahamS.L., GoldbergI., MurrayB., BeaumontP., ChongB.H.. Activated protein C resistance-low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion.Australian & New Zealand J Ophthalmol1996; 24: 199–205.
90.
LarssonJ., SellmanA., BauerB.. Activated protein C resistance in patients with central retinal vein occlusion.Br J Ophthalmol1997; 81: 832–4.
91.
CiardellaA.P., YannuzziL.A., FreundK.B.Factor V Leiden, activated protein C resistance, and retinal vein occlusion.Retina1998; 18: 308–15.
92.
ChabanelA., BernardA.G., LelongF., TaccoenA., CoscasG., SamamaM.M.. Increased red blood cell aggregation in retinal vein occlusion.Br J Hematol1990; 75: 127–31.
93.
ArendO., RemkyA., JungF., KiesewetterH., ReimM., WolfS.. Role of rheologic factors in patients with acute central retinal vein occlusion.Ophthalmology1996; 103: 80–6.
94.
TropeG.H., LoweG.D.O., McArdleB.M.Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion.Br J Ophthalmol1983; 67: 137–42.
95.
PeduzziM., DebbiaA., GuerrieriF., BolzaniR.. Abnormal blood rheology in retinal vein occlusion: a preliminary report.Graefe's Arch Clin Exp Ophthal1986; 224: 83–5.
EnzenauerR.W., BrozettiJ.J., DragooR.A.. Central retinal vein occlusion in a patient with IgG lambda monoclonal gammopathy.Arch Ophthalmol1999; 117: 134–5.
98.
TsaiR.K., ChangC.H.. Central retinal vein occlusion associated with cryofibrinogenemia in a young adult-study of skin dynamic capillaroscopy.J Formosan Med Assoc1998; 97: 777–9.
99.
OhK.T., BoldtH.C., DanisR.P.. Iatrogenic central retinal vein occlusion and hyperviscosity associated with high-dose intravenous immunoglobulin administration.Am J Ophthalmol1997; 124: 416–8.
100.
BandelloF., D'AngeloS.V., ParlavecchiaM.Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion.Thromb Haem1994; 72: 39–43.
101.
IijimaH., GohdoT., TsukaharaS.. Familial dysplasminogenemia with central retinal vein and cilioretinal artery occlusion.Am J Ophthalmol1998; 126: 312–4.
102.
LipP.L., BlannA.D., JonesA.F., LipG.Y.. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.Eye1998; 12: 245–51.
103.
DyerbergJ., StoffersenE.. Recurrent thrombosis in a patient with factor XII deficiency.Acta Haemat1980; 63: 278–82.
104.
McPhersonR.A.. Thromboembolism in Hageman trait.Am J Clin Path1977; 68: 420–3.
105.
AznarJ., FernandezP.A.. Thromboembolic accidents in patients with congenital deficiency of factor XII.Thromb Diath Haemorrh1974; 31: 525–6.
106.
SpeicherL., PhilippW., KunzF.J.. Factor XII deficiency and central retinal vein occlusion.Lancet1992; 340: 237.
107.
KazamaM., TaharaC., SuzukiZ., GohchiK., AbeT.. Abnormal plasminogen, a case of recurrent thrombosis.Thromb Res1981; 21: 517–22.
108.
SoriaJ., SoriaC., BertrandO., DunnF., DrouetL., CaenJ.P.. Plasminogen Paris I. Congenital abnormal plasminogen and its incidence in thrombosis.Thromb Res1983; 32: 229–38.
109.
PandolfiM., HednerN., NilssonI.M.. Bilateral occlusion of the retinal veins in a patient with inhibition fibrinolysis.Ann Ophthalmol1970; 2: 481–4.
110.
EricksonL.A., SchleefR.R., NyT., LoskutoffD.J.. The fibrinolytic system of the vascular wall.Clin Haem1985; 14: 513–30.
111.
HarrisE.N., BosK.. An acute disseminated coagulopathy-vasculopathy associated with the antiphospholipid syndrome (Editorial).Arch Intern Med1991; 151: 231–3.
HarrisE.N., ChanJ.K., AshersonR.A., AberV.R., GharaviA.E., HughesG.R.. Thrombosis, recurrent fetal loss, & thrombocytopenia. Predictive value of the anticardiolipin antibody test.Arch Intern Med1986; 146: 2153–6.
114.
FreyssinetJ.M., WieselM.L., GauchyJ., BoneuB., CazenaveJ.P.. An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity-a mechanism for thrombosis.Thromb Haemost1986; 55: 309–13.
115.
MalinowM.R., KangS.S., TaylorL.M.Prevalence of hyperhomocysteinemia in patients with peripheral arterial occlusive disease.Circulation1989; 79: 1180–8.
116.
BoersG.H., SmalsA.G., TrijbelsF.J.Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease.N Engl J Med1985; 313: 709–15.
117.
BrattstromL.E., HardeboJ.E., HultbergB.L.. Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease.Stroke1984; 15: 1012–6.
118.
ClarkeR., DalyL., RobinsonK., NaughtenE., CahalaneS., FowlerB., GrahamI.. Hyperhomocysteinemia, an independent risk factor for vascular disease.N Engl J Med1991; 324: 1149–55.
119.
MuddS.H., SkovbyF., LevyH.L.The natural history of homocystinuria due to cystathione-beta synthetase deficiency.Am J Hum Genet1985; 37: 1–31.
120.
MalinowM.R.. Hyperhomocysteinemia: a common and easily reversible risk factor for occlusive atherosclerosis.Circulation1990; 81: 2004–6.
121.
WenzlerE.M., RademakersA.J.J., BoersG.H., CruysbergJ.R.M., WebersC.A.B., DeutmanA.F.. Hyperhomocysteinemia in retinal artery and retinal vein occlusion.Am J Ophthalmol1993; 115: 162–7.
122.
RodgersG.M., ConnM.T.. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells.Blood1990; 75: 895–901.
123.
RodgersG.M., KaneW.H.. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.J Clin Invest1986; 77: 1909–16.
BiousseV., NewmanN.J., SternbergP.Jr.. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystinemia.Am J Ophthalmol1997; 124: 257–60.
126.
CastellaA., Othenin-GirardP.. Familial occlusion of central veins associated with Type II familial hyperlipoproteinemia.Klin Monatsbl Augenheilkd1992; 200: 346–8.
FriedmanS.M., MargoC.E.. Bilateral central retinal vein occlusions in a patient with acquired immunodeficiency syndrome. Clinicopathological correlation.Arch Ophthalmol1995; 113: 1184–8.
130.
StahlC.P., WidemanC.S., SpiraT.J., HaffE.C., HixonG.J., EvattB.L.. Protein S deficiency in men with long-term human immunodeficiency virus infection.Blood1993; 81: 1801–7.
131.
MansourA.M., LiH., SegalE.I.. Picture resembling hemicentral retinal vein occlusion in the acquired immunodeficiency syndrome: is it related to cytomegalovirus?Ophthalmologica1996; 210: 108–11.
132.
RuskellG.. The retinopial vein: a vein passing directly from the retina to the pia mater at the optic nerve head.Br J Ophthalmol1998; 82: 495–7.
KirwanJ.F., TsaloumasM.D., VinallH., PriorP., KritzingerE.E., DodsonP.M.. Sex hormone preparations and retinal vein occlusion.Eye1997; 11: 53–6.
135.
NagakiY., HayasakaS., HirakiS., YamadaY.. Central retinal vein occlusion in a woman receiving bromocriptine.Ophthalmologica1997; 211: 397–8.
136.
PrimoS.. Central retinal vein occlusion in a young patient with seropositive syphilis.J Am Optom Assoc1990; 61: 896–902.
137.
SmithJ.L.. Acute blindness in early syphilis.Arch Ophthalmol1973; 90: 256–8.
138.
El-AsrarA.M., AL-MomenA.K., AlamroS.A., GaderA.G., TabbaraK.F.. Bilateral central retinal vein thrombosis in Behçet's disease.Clin Rheum1996; 15: 511–3.
139.
IgarashiH., YanagawaC., IgarashiS.. Crohn's disease and central retinal vein occlusion.Indian J Ophthalmol1996; 44: 97–9.
140.
SmithP., GreenR., MillerN.R., TerryJ.M.. Central retinal vein occlusion in Reye's syndrome.Arch Ophthalmol1980; 98: 1256–60.
141.
GonderJ.R., MagargalL.E., WalshP.N., RaoK., DenenbergB.E.. Central retinal vein obstruction associated with mitral valve prolapse.Can J Ophthalmol1987; 31: 220–2.
142.
SchimkatM., HorstkotteD., SundmacherR.. Mitral valve prolapse. A possible cause of retinal vascular occlusion in young patients.Ophthalmolge1993; 90: 476–8.
143.
VanderVeenD.K., PasqualeL.R., FultonA.B.. Central retinal vein occlusion in a young child with cyanotic heart disease.Arch Ophthalmol1997; 115: 1077.
144.
SalzmannJ., JaggerJ.. Central retinal vein occlusion associated with the polycystic ovarian syndrome.Int J Clin Prac1997; 51: 339–41.
SharmaS., CruessA.F.. Central retinal vein occlusion associated with cavernous sinus thrombosis.Can J Ophthalmol1996; 31: 255–6.
147.
SlamovitsT.L., KlingeleT.G., BurdeR.M., GadoM.H.. Moyamoya disease with central retinal vein occlusion.J Clin Neuroophthalmol1981; 1: 123–7.
148.
AlleeS.D., MarksS.J.. Acute posterior multifocal placoid pigment epitheliopathy with bilateral central retinal vein occlusion.Am J Ophthalmol1998; 126: 309–12.
149.
HayrehS.S.. Central retinal vein occlusion: differential diagnosis and management.Trans Am Acad Ophthalmol Otolaryngol1977; 83: 379–91.
150.
HayrehS.S.. So called CRVO. II. Venous stasis retinopathy.Ophthalmologica1976; 172: 14–37.
151.
PettitJ.E., KohnerE.M., BulpittC.J., HamiltonA.J.. Proceedings: Fibrinolytic therapy in central retinal vein occlusion.Thromb Diath Haemorrh1975; 34: 569.
152.
KohnerE.M., LaatikainenL., OughtonJ.. The management of central retinal vein occlusion.Ophthalmology1983; 90: 484–7.
153.
HattenbachL.O., SteinkampG., ScharrerI., OhrloffC.. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion.Ophthalmologica1998; 212: 394–8.
154.
ReimM., BertramB., WolfS.. Treatment trials of plasminogen activator (rt-PA) in central retinal vein thrombosis of the retina.Klinische Wochenschrift1988; 66: 143–9.
155.
ElmanM.J.. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study.Trans Am Ophthalmol Soc1996; 94: 471–504.
156.
ArendshorstT.R., BurnsR.P., GoodnightS.Platelet inhibition therapy in ophthalmology.Symposium on ocular therapy.New York: John Wiley & Sons, 1976; 111.
157.
von KaullaE, von KaullaKN. Deficiency of antithrombin 3 activity associated with hereditary thrombosis tendency.J Med1972; 3: 349–58.
158.
HansenL.L., DanisevskisP., ArntzH.R.A randomized prospective study on treatment of central retinal vein occlusion by isovolemic haemodilution and photocoagulation.Br J Ophthalmol1985; 69: 108–16.
159.
SzaflikJ., RomaniukW., KoziolH.. Hemodilution in the treatment of central retinal vein thrombosis.Klin Oczna1991; 93: 132–3.
160.
OughtonJ., ChaineG., BarnesA.J.Effect of hemodilution on retinal blood flow.Clin Haemorheol1983; 3: 234.
161.
LuckieA.P., WroblewskiJ.J., HamiltonP.A randomised prospective study of outpatient haemodilution for central retinal vein obstruction.Aust N Z J Ophthalmol1996; 24: 223–32.
162.
McAllisterI.L., DouglasJ.P., ConstableI.J., YuD.Y.. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors.Am J Ophthalmol1998; 126: 219–29.
163.
McAllisterI.L., ConstableI.J.. Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion.Arch Ophthalmol1995; 113: 456–62.
FekratS., GoldbergM.F., FinkelsteinD.. Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion.Arch Ophthalmol1998; 116: 43–52.
166.
AktanS.G., SubasiM., AkbaturH., OrM.. Problems of chorioretinal venous anastomosis by laser for treatment of nonischemic central retinal vein occlusion.Ophthalmologica1998; 212: 389–93.
OpremackE.M., BruceR.A.. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy - A prospective review of 15 cases.Retina1999; 19: 1–5.
173.
Vasco-PosadaJ.. Modification of the circulation in the posterior pole of the eye.Ann Ophthalmol1972; 4: 48–59.
174.
WeissJ.N.. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein.Am J Ophthalmol1998; 126: 142–4.
175.
Central Vein Occlusion Study Group:A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group.Ophthalmology1995; 102: 1434–44.
176.
RoyM.S., MackayC.J., GourasP.. Cone ERG subnormality to red flash in central retinal vein occlusion: a predictor of ocular neovascularisation?Eye1997; 11: 335–41.
177.
BrowningD.J., ScottA.Q., PetersonC.B., WarnockJ., ZhangZ.. The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion.Ophthalmology1998; 105: 776–84.
178.
Central Vein Occlusion Study Group:Baseline and early natural history report. The Central Vein Occlusion Study.Arch Ophthalmol1993; 111: 1087–95.
179.
Central Vein Occlusion Study Group:Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report.Ophthalmology1995; 102: 1425–33.
180.
KiryuJ., OguraY.. Hyperbaric oxygen treatment for macular edema in retinal vein occlusion: relation to severity of retinal leakage.Ophthalmologica1996; 210: 168–70.
181.
SchaferA.I.. Thrombocytopenia and disorders of platelet function. In: SteinJ.H., ed. Internal medicine, ed 3.Boston: Little, Brown,1990: 1041.